After authorizing the Pfizer-BioNTech COVID-19 vaccine for emergency use in the USA for the past eight months, the Food and Drug Administration issued its approval.
The approval of Pfizer’s COVID vaccine was based on its six-month clinical trial of 44,000 people — half of whom got the shots, the company said.
Monday, President Joe Biden called on companies, nonprofit gro...
To access content, please login or purchase a subscription.